Kathryn Stein Email & Phone Number

Versatile cellular biologist with expertise in virology, AAV delivery, and host-microbe interactions. Experienced in performing high-throughput screening for the identification of virus host-entry factors and broadly neutralizing antibodies (Nat. Commun. 2019). Proficient in developing novel vaccine platforms, previously utilizing a chimeric influenza-HA with HCMV-gH immunogen (Vaccines 2019) and work harnessing the NOD2-activating SagA enzyme encoding Enterococcus sp. as an adjuvant and expression platform for SARS-CoV2 immunization. A demonstrated interest in the development of vaccines, antivirals, and the basic understandings of viral biology. Extensive technical skills within the laboratory, experienced scientific communicator, and effective project leader. Dedicated scientist as exhibited by numerous first and contributing author publications in respected journals, awarded fellowships, and attendance and talks at national conferences. Industry experience within process development on the analytics team, assisting both upstream and downstream with in-process testing, and recent work focusing on AAV production and capsid engineering.